These findings highlight molecular phenotypes (e.g., stemness, ALDH activity, tumor-promoting inflammation, and anti-oxidant function) that are prevalent in CSC-enriched spheres from Gprc5a−/− LUAD with somatically acquired driver Kras mutations. The gene discussed is GPRC5A; the disease is neoplasm.